STAT3 interactors as potential therapeutic targets for cancer treatment

F Laudisi, F Cherubini, G Monteleone… - International journal of …, 2018 - mdpi.com
Signal transducers and activators of transcription (STATs) mediate essential signaling
pathways in different biological processes, including immune responses, hematopoiesis …

MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis

SK Das, S Maji, SL Wechman, P Bhoopathi… - Pharmacological …, 2020 - Elsevier
The primary cause of cancer-related death from solid tumors is metastasis. While unraveling
the mechanisms of this complicated process continues, our ability to effectively target and …

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1-and estrogen receptor-containing transcription complexes

AR Daniel, AL Gaviglio, TP Knutson, JH Ostrander… - Oncogene, 2015 - nature.com
Progesterone and estrogen are important drivers of breast cancer proliferation. Herein, we
probed estrogen receptor-α (ER) and progesterone receptor (PR) cross-talk in breast cancer …

Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer

P Ravindranathan, TK Lee, L Yang… - Nature …, 2013 - nature.com
The growth of advanced prostate cancer depends on androgen receptor signalling, however
treatment options are limited. Here we report the disruption of specific protein–protein …

Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer

SS Roy, VK Gonugunta, A Bandyopadhyay, MK Rao… - Oncogene, 2014 - nature.com
Tumor metastasis is the leading cause of death among breast cancer patients. PELP1
(proline, glutamic acid and leucine rich protein 1) is a nuclear receptor coregulator that is …

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

KA Altwegg, S Viswanadhapalli, M Mann… - Cancer research, 2022 - AACR
Most patients with estrogen receptor alpha–positive (ER+) breast cancers initially respond to
treatment but eventually develop therapy resistance with disease progression …

Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer

V Cortez, M Mann, S Tekmal, T Suzuki, N Miyata… - Breast Cancer …, 2012 - Springer
Introduction The estrogen receptor (ER) co-regulator proline glutamic acid and leucine-rich
protein 1 (PELP1) is a proto-oncogene that modulates epigenetic changes on ER target …

PELP1 oncogenic functions involve CARM1 regulation

M Mann, V Cortez, R Vadlamudi - Carcinogenesis, 2013 - academic.oup.com
Estrogen receptor alpha (ERα) is implicated in the initiation and progression of breast
cancer and its transcription depends on the modulation of epigenetic changes at target gene …

Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer

L Yang, P Ravindranathan, M Ramanan… - Molecular …, 2012 - academic.oup.com
The ability of 17β-estradiol (E2) to regulate the proliferation of prostate cancer (PCa) cells in
the absence of androgen is poorly understood. Here, we show the predominant estrogen …

Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling

J Liu, Z Liu, M Li, W Tang, UP Pratap, Y Luo… - Molecular …, 2021 - Wiley Online Library
A significant proportion of estrogen receptor‐positive (ER+) breast cancer (BC) initially
responds to endocrine therapy but eventually evolves into therapy‐resistant BC …